RSS-Feed abonnieren
DOI: 10.1055/s-2003-41282
J. A. Barth Verlag in Georg Thieme Verlag Stuttgart · New York
The Ala45Thr Polymorphism of BETA2/NeuroD1 Gene and Susceptibility to Type 1 Diabetes Mellitus in Caucasians
Publikationsverlauf
Received: August 8, 2002
First decision: October 20, 2002
Accepted: January 16, 2003
Publikationsdatum:
02. September 2003 (online)
Abstract
It has recently been shown that mutations in BETA2/NeuroD1 are responsible for the development of type 2 diabetes mellitus (T2DM) in Caucasians. This gene is located near the IDDM7 region and one of its amino acid polymorphisms, Ala45Thr, has been associated with type 1 diabetes (T1DM) in Japanese and Danish populations. The aim of our study is to examine Ala45Thr for its role in T1DM in Caucasians.
We used both population-based case-control analysis and family-based transmission/disequilibrium testing (TDT). Genotyping was carried out by the dot-blotting method using P32. Study subjects comprised 202 type 1 diabetes cases (mean age at diagnosis: 11.1 years, mean age at examination: 36.4 years) and 139 controls with normal fasting glucose. For the TDT study, allelic transmission was evaluated in 209 case family trios.
The frequency of the Ala45 allele was 70.3 % in cases and 62.9 % in controls (p = 0.04), and 47.5 % of cases were Ala45 homozygotes compared to 36.0 % of controls (p = 0.03). The TDT component of the study did not achieve statistical significance. However, given the high frequency of this variant even among controls, exceptionally large data sets are needed to provide adequate power for this approach.
Our case-control study suggests that the Ala45 variant of BETA2/NeuroD1 may be associated with T1DM in Caucasians (or in linkage disequilibrium with a causative variant). However, this finding should be confirmed by a much larger family-based study.
Key words
Type 1 diabetes - BETA2/Neurod1 gene - genetic susceptibility
References
- 1 Altshuler D, Kruglyak L, Lander E. Genetic polymorphisms and disease. N Engl J Med. 1998; 338 1626
- 2 Ardlie K G, Lunetta K L, Seielstad M. Testing for population subdivision and association in four case-control studies. Am J Hum Genet. 2002; 71 304-311
- 3 Awata T, Inoue K, Inoue I, Abe T, Takino H, Kanazawa Y, Katayama S. Lack of association of the Ala45Thr variant in the BETA2/NEUROD1 with type 1 diabetes in Japanese. Diabetes Res Clin Pract. 2000; 49 61-63
- 4 Chu K, Nemoz-Gaillard E, Tsai M J. BETA2 and pancreatic islet development. Recent Prog Horm Res. 2001; 56 23-46
- 5 Cox N J, Wapelhorst B, Morrison V A, Johnson L, Pinchuk L, Spielman R S, Todd J A, Concannon P. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet. 2001; 69 820-830
- 6 Esposito L, Hill N J, Pritchard L E, Cucca F, Muxworthy C, Merriman M E, Wilson A, Julier C, Delepine M, Tuomilehto J, Tuomilehto-Wolf E, Ionesco-Tirgoviste C, Nistico L, Buzzetti R, Pozzilli P, Ferrari M, Bosi E, Pociot F, Nerup J, Bain S C, Todd J A. Genetic analysis of chromosome 2 in type 1 diabetes: analysis of putative loci IDDM 7, IDDM 12, and IDDM 13 and candidate genes NRAMP1 and IA-2 and the interleukin-1 gene cluster. IMDIAB Group. Diabetes. 1998; 47 1797-1799
- 7 Hansen L, Jensen J N, Urioste S, Petersen H V, Pociot F, Eiberg H, Kristiansen O P, Hansen T, Serup P, Nerup J, Pedersen O. NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an Ala45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics Group. Diabetes. 2000; 49 876
- 8 Iwata I, Nagafuchi S, Nakashima H, Kondo S, Koga T, Yokogawa Y, Akashi T, Shibuya T, Umeno Y, Okeda T, Shibata S, Kono S, Yasunami M, Ohkubo H, Niho Y. Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the Japanese. Diabetes. 1999; 48 416-419
-
9 Warram J II, Rich S S, Krolewski A S.
Epidemiology and genetics of diabetes mellitus. Kahn CR, Weir GC Joslin's Diabetes Mellitus. 13th ed. Philadelphia; Lea & Febige 1994: 201-215 - 10 Knapp M. A note on power approximations for the transmission/disequilibrium test. Am J Hum Genet. 1999; 64 1177-1185
- 11 Krolewski A S, Laffel L M, Krolewski M, Quinn M, Warram J H. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med May. 1995; 332 1251-1255
- 12 Malecki M T, Jhala U S, Antonellis A, Fields L, Orban T, Saad M, Doria A, Warram J H, Montminy M, Krolewski A S. Mutations in the BETA2/NEUROD1 gene are associated with the development of type 2 diabetes mellitus. Nat Genet. 1999; 23 323-328
- 13 Morton N E, Collins A. Tests and estimates of allelic association in complex inheritance. Proc Natl Acad Sci USA. 1998; 95 11389-11393
- 14 Naya F J, Huang H P, Qiu Y, Mutoh H, DeMayo F J, Leiter A B, Tsai M J. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev. 1997; 11 2323-2334
- 15 Naya F J, Stellrecht C M, Tsai M J. Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes Dev. 1995; 9 1009-1019
- 16 Owerbach D, Naya F J, Tsai M J, Allander S V, Powell D R, Gabbay K H. Analysis of candidate genes for susceptibility to type I diabetes: a case-control and family-association study of genes on chromosome 2q31 - 35. Diabetes. 1997; 46 1069-1074
- 17 Rogus J J, Warram J H, Krolewski A S. Genetic studies of late diabetic complications: the overlooked importance of diabetes duration prior to complication onset. Diabetes. 2002; 51 1655-1662
- 18 Scott L, Rogus J J. Using unaffected child trios to test for transmission distortion. Genet Epidemiol. 2000; 19 381-394
- 19 Spielman R S, McGinnis R E, Ewens W J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993; 52 506-516
- 20 Todd J A, Farrall M. Panning for gold: genome-wide scanning for linkage in type 1 diabetes. Hum Mol Genet. 1996; 5 1443-1448
Dr. John J. Rogus
Section on Genetics and Epidemiology, Joslin Diabetes Center
One Joslin Place
Boston, MA 02215-5397
USA
Telefon: + 16177322668
Fax: + 1 61 77 32 24 32
eMail: John.Rogus@joslin.harvard.edu